Posted by Michael Wonder on 29 Oct 2019
UK officials discussed NHS at ‘secret’ meetings with US drug companies as part of trade talks
29 October 2019 - Envoys sidestep ban on discussing drug prices by referring to controversial subject ‘valuing innovation’.
Senior British civil servants have met with representatives from a US companies to discuss the NHS in post-Brexit trade negotiations, it has been revealed.
Over a third of people surveyed in a recent poll saying they were “very concerned” about the future impact of a deal with Washington on the service.
